Decreased hemojuvelin protein levels in mask mice lacking matriptase-2-dependent proteolytic activity

J Frýdlová1, Y Fujikura, M Vokurka

  • 1Institute of Pathophysiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jkri@lf1.cuni.cz

Physiological Research
|April 18, 2013
PubMed

Insights

Matriptase-2 deficiency paradoxically reduces hemojuvelin protein levels in mice, while enhancing bone morphogenetic protein signaling. Further research is needed to clarify this regulatory mechanism.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Matriptase-2 (encoded by Tmprss6) negatively regulates hepcidin.
  • Previous studies suggested matriptase-2 cleaves membrane hemojuvelin.
  • Recent findings indicated decreased hemojuvelin protein in Tmprss6 knockout mice.

Purpose of the Study:

  • Confirm decreased hemojuvelin protein levels in a different mouse strain lacking Tmprss6.
  • Investigate matriptase-2 deficiency effects on bone morphogenetic protein (BMP) signaling pathway membrane proteins.

Main Methods:

  • Analysis of hemojuvelin protein levels in mask mice (lacking matriptase-2 proteolytic domain).
  • Measurement of Id1 mRNA levels as an indicator of BMP signaling.
  • Assessment of bone morphogenetic protein receptors (Alk3, Acvr2a), transferrin receptor 2, and neogenin protein levels.

Main Results:

  • Mask mice showed decreased liver hemojuvelin protein content.
  • Id1 mRNA levels were increased, indicating enhanced BMP signaling.
  • Alk3 and Acvr2a receptor levels remained unchanged; transferrin receptor 2 and neogenin levels slightly decreased.

Conclusions:

  • Loss of matriptase-2 proteolytic activity enhances BMP-dependent signaling.
  • This occurs concurrently with a paradoxical decrease in liver hemojuvelin protein levels.
  • The mechanism linking matriptase-2 deficiency to reduced hemojuvelin remains unclear.

Related Concept Videos